CDC, NCCLS, and OSHA Guidelines for Universal Precautions: Who is right and are the Guidelines Practical?

  • Stanley Bauer


Universal Precautions as recommended by the Centers for Disease Control (CDC) in 1987 (1) and updated in 1988 (2) have been widely adopted and form an integral part of the regulatory activity of the Occupational Safety and Health Administration (OSHA) and state regulatory agencies. Universal precautions as promulgated by the CDC imply the use of Blood and Body Fluid Isolation for all patients regardless of any lack of evidence of an infection with hepatitis B virus (HBV), human immunodeficiency virus (HIV), or other blood-borne infection. The implementation of universal precautions has raised many issues which have not been officially addressed by the CDC or OSHA.


Human Immunodeficiency Virus Human Immunodeficiency Virus Infection Human Immunodeficiency Virus Infected Patient Universal Precaution Needlestick Injury 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    CDC. 1987. Recommendations for the prevention of HIV transmission in health-care settings. MMWR. 36(suppl no. 2S):3s.Google Scholar
  2. 2.
    CDC. 1988. Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis 3 virus, and other bloodborne pathogens in health-care settings. MMWR. 37:377–388.Google Scholar
  3. 3.
    Garner, J.S. and B.P. Simmons. 1983, Guideline for isolation precautions in hospitals, Infect. Control 4:245–325.PubMedGoogle Scholar
  4. 4.
    CDC. 1981. Pneumocystis pneumonia-Los Angeles. MMWR. 30:250–252.Google Scholar
  5. 5.
    CDC. 1987. AIDS: Recommendations and guidelines, November 1982-November 1986. (U.S. Government Printing Office: 1987-732-950/40505), US Department of Health and Human Services, Public Health Service, Atlanta.Google Scholar
  6. 6.
    NCCLS. 1987. Protection of laboratory workers from infectious disease transmitted by blood and tissue; Proposed Guideline. NCCLS Document M29-P. National Committee for Clinical Laboratory Standards, Villanova.Google Scholar
  7. 7.
    Department of Labor, Department of Health and Human Services. 1987. Joint advisory notice: Protection against occupational exposure to hepatitis B virus (HBV) and human immunodeficiency virus (HIV). US Department of Labor, US Department of Health and Human Services, Washington.Google Scholar
  8. 8.
    OSHA. 1988. Enforcement procedures for occupational exposure to hepatitis 3 virus (HBV), human immunodeficiency virus (HIV), and other blood-borne infectious agents in health care facilities. OSHA Instruction CPL 2-2.44. OSHA, Washington.Google Scholar
  9. 9.
    OSHA. 1988. Enforcement procedures for occupational exposure to hepatitis B virus (HBV) and human immunodeficiency virus (HIV). OSHA instruction CPL 2-2.44A, August 15, 1988. OSHA, Washington.Google Scholar
  10. 10.
    NCCLS. 1988. Protection of laboratory workers from infectious diseases transmitted by bloodr body fluids, and tissue; Tentative Guideline. NCCLS Document M29-T. National Committee for Clinical Laboratory Standards, Villanova.Google Scholar
  11. 11.
    Ziza, J.M., F. Brun-Vezinet, A. Venet, C.H. Rouzioux, J. Traversat, B. Israel-Biet, F. Barre-Sinoussi, J.C. Chermann, and P. Godeau. 1985. Lymphadenopathy-associated virus isolated from bronchoalveolar lavage fluid on AIDS-related complex with lymphoid interstitial pneumonitis. N. Engl. J. Med. 313:183.PubMedGoogle Scholar
  12. 12.
    Grady, G.F., V.A. Lee, A.M. Prince, G.L. Gitnick, K.A. Fawaz, G.N. Vyas, M.D. Levitt, J.R. Senior, J.T. Galambos, T.E. Bynum, J.W. Singleton, B.F. Clowdus, K. Akdamar, R.D. Aach, E.I. Winkelman, G.M. Schiff, and T. Hersh. 1978. Hepatitis B immune globulin for accidental exposures among medical personnel: Final report of a multi-center controlled trial. J. Infect. Dis. 138:625–638.PubMedCrossRefGoogle Scholar
  13. 13.
    Seeff, L.B. 1978. Type B hepatitis after needlestick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. Ann. Intern. Med. 88:285–293.PubMedGoogle Scholar
  14. 14.
    Vlahov, D. and B.F. Polk. 1987. Transmission of human immunodeficiency virus within the health care setting. Occupational Medicine: State of the Art Rev. 2:429–450.Google Scholar
  15. 15.
    Gerberding, J.L., C.E. Bryant-LeBlanc, K. Nelson, A.R. Moss, D. Osmund, H.F. Chambers, J.R. Carlson, W.L. Drew, J.A. Levy, and M.A. Sande. 1987. Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J. Infect. Dis. 156:1–8.PubMedCrossRefGoogle Scholar
  16. 16.
    CDC. 1988. Quarterly report to the domestic policy council on the prevalence and rate of spread of HIV and AIDS — united States. MMWR. 37:551–559.Google Scholar
  17. 17.
    CDC. 1987. Human immunodeficiency virus in the united States: A review of current knowledge. MMWR. 36 (suppl. no. s-6)Google Scholar
  18. 18.
    CDC. 1987. Human immunodeficiency virus infection in transfusion recipients and their family members. MMWR. 36:137–140.Google Scholar
  19. 19.
    CDC. 1987. Trends in human immunodeficiency virus infection among civilian applicants for military service — united States, October 1985–December 1986. MMWR. 36:273–274.Google Scholar
  20. 20.
    Lifson, A.R., T.W. Bodecker, J.L. Barnhart, P.M. O’Malley, G.F. Lemp, N.A. Hessol, D.R. Franks, J.J. Cambell, D. Werdegar, H.W. Jaffe, and G.W. Rutherford. 1987. AIDS in the S.F. city cohort study. Program and Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington.Google Scholar
  21. 21.
    Robert-Guroff, M., S.H. Weiss, J.A. Giron, A.M. Jennings, I.B. Margolis, W.A. Blattner, and R.C. Gallo. 1986. Prevalence of antibodies to HTLV-I,-II, and-III in in travenous drug abusers from an AIDS endemic region. JAMA. 155:151–152.Google Scholar
  22. 22.
    Friedland, G.H. and R.S. Klein. 1987. Transmission of the human immunodeficiency virus. N. Engl. J. Med. 317:1125–1135.PubMedCrossRefGoogle Scholar
  23. 23.
    CDC. 1987. HIV infection and pregnancies in sexual partners of HIV-seropositive hemophiliac men — United States. MMWR. 36:593–595.Google Scholar
  24. 24.
    Hoofnagle, J.H. 1985. Hepatitis. Principles and Practices of Infectious Diseases, 2nd Ed. G.L. Mandell, R.G. Douglas, and J.E. Bennett (eds.), John Wiley & Sons, New York.Google Scholar
  25. 25.
    CDC. 1984. Adult immunization: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR. (suppl no. IS): 5s-6s.Google Scholar
  26. 26.
    Wormser, G. P, C.S. Rabkin, and C. Jolin. 1988. Frequency of nosocomial transmission of HIV infection among health care workers. N. Engl. J. Med. 319:307–308.PubMedCrossRefGoogle Scholar
  27. 27.
    CDC. 1988. update: Acquired immunodeficiency syndrome and human immunodeficiency virus infection among health-care workers. MMWR. 37:229–239.Google Scholar
  28. 28.
    Redfield, R.R. and D.S. Burke. 1988. HIV infection: The clinical picture. Scientific American 259:90–98.PubMedCrossRefGoogle Scholar
  29. 29.
    Palmer, D.L., M. Barash, R. King, and F. Neil. 1983. Hepatitis among hospital employees. Western J. Med. 138:519–523.Google Scholar
  30. 30.
    Favero, M.S., J.P. Petersen, W.W. Bond. 1986. Transmission and control of laboratory-acquired hepatitis infection. Laboratory Safety: Principles and Practices. B.M. Miller, D.H.M. Groschel, J.H. Richardson, D. Vesley, J.R. Songer, R.D. Housewright, and W.E. Barkley (eds.), American Society for Microbiology, Washington.Google Scholar
  31. 31.
    Ranki, A., S.L. Valle, M. Krohn, J. Antonen, J.P. Allain, M. Leuther, G. Franchini, and K. Krohn. 1987. Long latency precedes overt seroconversion in sexually transmitted human immunodeficiency virus infection. Lancet ii:589–593.CrossRefGoogle Scholar
  32. 32.
    Casareale, D., S. Dewhurst, J. Sonnabend, F. Sinangil, D.T. Purtilo, and D.H. Volsky. 1984–1985. Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village. AIDS Res. Hum. Retroviruses 1:407–421.Google Scholar
  33. 33.
    Feorino, P., B. Forrester, C. Schable, D. Warfield, G. Schochetman. 1987. Comparison of antigen assay and reverse transcriptase assay for detecting human immunodeficiency virus in culture. J. Clin. Microbiol. 25:2344–2346.PubMedGoogle Scholar
  34. 34.
    Gerberding, J.L. 1986. The University of California-San Francisco Task Force on Aids: Recommended infection-control policies for patients with human immunodeficiency virus infection. N. Engl. J. Med. 315:1562–1563.PubMedCrossRefGoogle Scholar
  35. 35.
    Lynch, P., M.N. Jackson, M.J. Cummings, and W.E. Stamm. Rethinking the role of isolation practices in the prevention of nosocomial infections. Ann. Intern. Med. 107:243–250.Google Scholar
  36. CDC. 1985. Recommendations of the immunization practices advisory committee. MMWR. 34:313–324, 329-335.Google Scholar
  37. 36.
    CDC. 1985. Recommendations of the immunization advisory committee. MMWR. 34:313–324, 329-335.Google Scholar
  38. 37.
    CDC. 1986. Recommendations of the immunization practices advisory committee — Update on hepatitis B prevention. MMWR. 36:353–366.Google Scholar
  39. 38.
    Ruprecht, R.M., L.G. O’Bien, L.D. Rossoni, and S. Nusinoff-Lehrman 1986. Suppression of mouse viremia and retroviral disease by 3′-azido-3′-deoxythymidine. Nature 323:467–469.PubMedCrossRefGoogle Scholar
  40. 39.
    Sharpe, A.H., R. Jaenisch, and R.M. Ruprecht. 1987. Retroviruses and mouse embryos: A rapid model for neuro virulence and transplacental antiviral therapy. Science 236:1671–1674.PubMedCrossRefGoogle Scholar
  41. 40.
    Ou, C.Y., S. Kwok, S.W. Mitchell, D.H. Mack, J.J. Snisky, J.W. Krebs, P. Feorino, D. Warfield, and G. Schochetman. 1988. DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 239:295–297.PubMedCrossRefGoogle Scholar
  42. 41.
    CDC. 1988. 1988 Agent summary statement for human immunodeficiency virus and report on laboratory-acquired infec tion with human immunodeficiency virus. MMWR. 37(suppl. no. S-4):1S–22S.Google Scholar
  43. 42.
    Koop, C.E. 1987. Surgeon General’s Report on acquired immunodeficiency syndrome. U.S. Department of Health and Human Services, Public Health Service, Washington.Google Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Stanley Bauer
    • 1
    • 2
  1. 1.Department of PathologyThe Bronx-Lebanon Hospital CenterBronxUSA
  2. 2.The National Committee for Clinical Laboratory StandardsVillanovaUSA

Personalised recommendations